Nuvectis Pharma Stock (NASDAQ: NVCT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 100.64K |
Day Range | - - - |
52 Wk Range | 5.85 - 14.96 |
Market Cap | $121.24M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 9.75% |
Days to Cover | 6.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nuvectis Pharma (NASDAQ:NVCT) through any online brokerage.
Other companies in Nuvectis Pharma’s space includes: Anixa Biosciences (NASDAQ:ANIX), Citius Oncology (NASDAQ:CTOR), Adicet Bio (NASDAQ:ACET), Agenus (NASDAQ:AGEN) and aTyr Pharma (NASDAQ:ATYR).
Nuvectis Pharma has a consensus price target of $21.00.
The stock price for Nuvectis Pharma (NASDAQ: NVCT) is $6.5 last updated September 20, 2024 at 4:34 PM EDT.
There are no upcoming dividends for Nuvectis Pharma.
Nuvectis Pharma’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Nuvectis Pharma.
Nuvectis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.